Relationship between mean platelet volume and metabolic syndrome in Chinese patients

被引:19
作者
Zhao, Fengxiao [1 ]
Yan, Ziyu [1 ]
Meng, Zhaowei [1 ]
Li, Xue [1 ]
Liu, Ming [2 ]
Ren, Xiaojun [2 ]
Zhu, Mei [2 ]
He, Qing [2 ]
Zhang, Qing [3 ]
Song, Kun [3 ]
Jia, Qiyu [3 ]
Zhang, Chunmei [1 ]
Wang, Huiying [1 ]
Liu, Xiaoxia [1 ]
Zhang, Xuemei [1 ]
Wang, Xiaoran [1 ]
Pan, Zhengzhou [1 ]
Liu, Xiangxiang [1 ]
Zhang, Wan [1 ]
机构
[1] Tianjin Med Univ, Dept Nucl Med, Gen Hosp, Tianjin, Peoples R China
[2] Tianjin Med Univ, Dept Endocrinol & Metab, Gen Hosp, Tianjin, Peoples R China
[3] Tianjin Med Univ, Gen Hosp, Dept Hlth Management, Tianjin, Peoples R China
关键词
COUNT; HYPERURICEMIA; ASSOCIATION;
D O I
10.1038/s41598-018-32751-1
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mean platelet volume (MPV) is a determinant of activation and variability of platelets (PLT). The focus of this study was to to investigate MPV values in patients with and without metabolic syndrome (MS). It also evaluates the association between them. There are close connections among MPV, MS, and cardiometabolic risk. We compiled age, body mass index, blood cell counts, MPV, and other data of 59976 self-reported healthy volunteers (28428 male, 31548 female), 24.65% of who have MS. The mean age of the group was 48.21 years old. The data was grouped by sex and values of data between men and women groups were analyzed by independent sample's t-test. The relationship between sex and MS was evaluated by chi-square tests. Crude odd ratios of MS between MPV quartiles and 95% confidence intervals were analyzed by binary logistic regression in this study. We found women had higher levels of MPV (10.09 vs. 9.98, P < 0.01) and PLT (228.68 vs. 212.11, P < 0.01) than men. In females, the prevalence of MS was higher in low MPV group than in high MPV groups. The odds of having MS were significantly lower in higher MPV quartiles compared with MPV Quartile 1 in women (Adjusted OR < 1, P < 0.01). This study indicated that MS was inversely associated with MPV in females only.
引用
收藏
页数:6
相关论文
共 30 条
[1]   Could mean platelet volume among complete blood count parameters be a surrogate marker of metabolic syndrome in pre-pubertal children? [J].
Aypak, Cenk ;
Turedi, Ozlem ;
Bircan, Mustafa A. ;
Yuce, Adnan .
PLATELETS, 2014, 25 (06) :393-398
[2]   Interleukin-6 and megakaryocytopoiesis: An update [J].
Baatout, S .
ANNALS OF HEMATOLOGY, 1996, 73 (04) :157-162
[3]   The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment [J].
Coban, Erkan ;
Afacan, Berna .
PLATELETS, 2008, 19 (02) :111-114
[4]   White Blood Cell Count to Mean Platelet Volume Ratio Is a Prognostic Factor in Patients with Non-ST Elevation Acute Coronary Syndrome with or without Metabolic Syndrome [J].
Dehghani, Mohammad Reza ;
Rezaei, Yousef ;
Fakour, Sanam ;
Arjmand, Nasim .
KOREAN CIRCULATION JOURNAL, 2016, 46 (02) :229-238
[5]   Effects of doxazosin and amlodipine on mean platelet volume and serum serotonin level in patients with metabolic syndrome - A randomised, controlled study [J].
Demirtunc, Refik ;
Duman, Dursun ;
Basar, Melih .
CLINICAL DRUG INVESTIGATION, 2007, 27 (06) :435-441
[6]   Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].
Dormandy, JA ;
Charbonnel, B ;
Eckland, DJA ;
Erdmann, E ;
Massi-Benedetti, M ;
Kmoules, IK ;
Skene, AM ;
Tan, MH ;
Lefébvre, PJ ;
Murray, GD ;
Standl, E ;
Wilcox, RG ;
Wlhelmsen, L ;
Betteridge, J ;
Birkeland, K ;
Golay, A ;
Heine, RJ ;
Korányi, L ;
Laakso, M ;
Mokán, M ;
Norkus, A ;
Pirags, V ;
Podar, T ;
Scheen, A ;
Scherbaum, W ;
Schernthaner, G ;
Schmitz, O ;
Skrha, J ;
Smith, U ;
Taton, J .
LANCET, 2005, 366 (9493) :1279-1289
[7]   Linking inflammation and thrombosis: Role of C-reactive protein [J].
Fay, William P. .
WORLD JOURNAL OF CARDIOLOGY, 2010, 2 (11) :365-369
[8]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[9]   Clinical Management of Metabolic Syndrome - Report of the American heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management [J].
Grundy, SM ;
Hansen, B ;
Smith, SC ;
Cleeman, JI ;
Kahn, RA .
CIRCULATION, 2004, 109 (04) :551-556
[10]   Angiotensin II can induce and potentiate shape change in human platelets: effect of losartarn [J].
Jagroop, IA ;
Mikhailidis, DP .
JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (09) :581-585